Silvercrest Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,560
| Closed | -$147K | – | 596 |
|
|
2017
Q3 | $147K | Hold |
11,560
| – | – | ﹤0.01% | 542 |
|
|
2017
Q2 | $137K | Hold |
11,560
| – | – | ﹤0.01% | 526 |
|
|
2017
Q1 | $171K | Hold |
11,560
| – | – | ﹤0.01% | 556 |
|
|
2016
Q4 | $187K | Sell |
11,560
-1,000
| -8% | -$16.2K | ﹤0.01% | 560 |
|
|
2016
Q3 | $228K | Sell |
12,560
-3,000
| -19% | -$54.5K | ﹤0.01% | 501 |
|
|
2016
Q2 | $256K | Sell |
15,560
-1,000
| -6% | -$16.5K | ﹤0.01% | 492 |
|
|
2016
Q1 | $274K | Hold |
16,560
| – | – | ﹤0.01% | 477 |
|
|
2015
Q4 | $359K | Hold |
16,560
| – | – | 0.01% | 461 |
|
|
2015
Q3 | $328K | Sell |
16,560
-2,000
| -11% | -$39.6K | 0.01% | 410 |
|
|
2015
Q2 | $645K | Hold |
18,560
| – | – | 0.01% | 376 |
|
|
2015
Q1 | $482K | Sell |
18,560
-7,600
| -29% | -$197K | 0.01% | 378 |
|
|
2014
Q4 | $337K | Buy |
+26,160
| New | +$337K | ﹤0.01% | 393 |
|